Asthma changes at a pediatric intensive care unit after 10 years: Observational study

Ayman A Al-Eyadhy1, Mohamad-Hani Temsah1, Ali A N Alhaboob1

  • 1Pediatric Intensive Care Unit, Department of Pediatrics, College of Medicine, King Khalid University Hospital, King Saud University, Riyadh, Saudi Arabia.

Annals of Thoracic Medicine
|December 15, 2015
PubMed

Insights

Management of pediatric severe asthma has evolved, with increased Pediatric Intensive Care Unit (PICU) admissions and greater use of inhaled ipratropium bromide and non-invasive ventilation (NIV). This shift in treatment for acute severe asthma (ASA) occurred in a tertiary care setting.

Area of Science:

  • Pediatric critical care medicine
  • Respiratory medicine
  • Asthma management

Background:

  • Acute severe asthma (ASA) in children requires intensive management.
  • Previous treatment protocols and outcomes for pediatric ASA were established in 2003.
  • Tertiary care centers play a crucial role in managing severe pediatric respiratory conditions.

Purpose of the Study:

  • To compare the management and outcomes of pediatric patients with ASA admitted to the Pediatric Intensive Care Unit (PICU).
  • To evaluate changes in treatment strategies for ASA over a decade (2003 vs. 2013).
  • To assess the impact of evolving medical practices on pediatric ASA patient care.

Main Methods:

  • Retrospective observational study design.
  • Inclusion of all consecutive pediatric ASA patients admitted to the PICU.
  • Comparison of a 2013 cohort with a previously published 2003 cohort from the same institution.

Main Results:

  • The 2013 cohort showed a higher mean age and a significantly increased rate of PICU admissions compared to the 2003 cohort.
  • Increased utilization of inhaled ipratropium bromide, intravenous magnesium sulfate, and non-invasive ventilation (NIV) in the 2013 cohort.
  • Decreased use of maintenance inhaled steroids and theophylline, with no patients requiring intubation or experiencing mortality in the 2013 cohort.

Conclusions:

  • Pediatric ASA management has shifted towards older children and increased PICU admission rates.
  • The use of inhaled ipratropium bromide, magnesium sulfate, and NIV has become more prevalent in treating pediatric ASA.
  • Current management strategies for pediatric ASA in tertiary care settings have led to favorable outcomes without mortality or intubation.
Abstract

Related Concept Videos